Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 5, 1999, Pages 1722-1728

  Pugliese, Alberto ^a   Kawasaki, Eiji ^b,c   Zeller, Markus ^a   Yu, Liping ^c   Babu, Sunanda ^c   Solimena, Michele ^d   Moraes, Carlos T ^a   Pietropaolo, Massimo ^e   Friday, Robert P ^e   Trucco, Massimo ^e   Ricordi, Camillo ^a   Allen, Marie ^f   Noble, Janelle A ^f,g   Erlich, Henry A ^g   Eisenbarth, George S ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f ROCHE MOLECULAR SYSTEMS   (United States)

^g CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; MITOCHONDRIAL DNA; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENE SEQUENCE; HAPLOTYPE; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ONSET AGE; PRIORITY JOURNAL; PROTECTION; RELATIVE; SEQUENCE ANALYSIS;

EID: 0033311161     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.5.1722     Document Type: Article

References (72)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Human type I diabetes mellitus: Genetic susceptibility and resistance
3. A genome-wide search for human type 1 diabetes susceptibility genes
4. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families
5. MHC class-II molecules, and autoimmunity
6. HLA-DQ β gene contribution to susceptibility and resistance to insulin dependent diabetes mellitus
7. Allelic sequence variation of the HLA-DQ loci: Relationship to serology, and to insulin-dependent diabetes mellitus susceptibility
8. Aspartic acid at position 57 of the HLA-DQ β chain protects against type I diabetes: A family study
9. A diabetes susceptible HLA haplotype is best defined by a combination of HLA-DR, and DQ alleles
10. HLA-DQB sequence polymorphism and genetic susceptibility to IDDM
11. HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus
12. Combination of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia
13. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM)
14. DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes
15. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection
16. An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy
17. A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility
18. Extensive study of DRβ, DQα, and DQβ gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients
19. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese
20. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus
21. 52 confers susceptibility to insulin-dependent diabetes mellitus
22. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus
23. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-base affected families and controls
24. Glutamate decarboxylase-, insulin-, islet cell antibodies, and HLA typing to detect diabetes in a general population-based study of Swedish children
25. High frequency of aspartic acid at position 57 of HLA-DQ β-chain in Japanese IDDM patients and nondiabetic subjects
26. Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus
27. Susceptibility to IDDM in a Chinese population
28. HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a black population
29. Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus
30. HLA class II alleles, and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families
31. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes
32. Genetic protection from insulin-dependent diabetes mellitus
33. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes
34. High risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies but DQB1*0602 does not prevent their expression
35. The Diabetes Prevention Trial-type 1 diabetes (DPT-1): Implementation of screening and staging of relatives
36. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes
37. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics
38. Islet cell antibodies in diabetes mellitus associated with a mitochondrial tRNA (Leu(UUR)) gene mutation
39. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial mutation at base pair 3243
40. Clinical aspects of mitochondrial diabetes
41. Diabetes and mithocondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS): Radiolabeled polymerase chain reaction is necessary for accurate detection of low percentages of mutation
42. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
43. Association of HLA-DQB1*0201 with stiff-man syndrome
44. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiffman syndrome
45. Stiff-man syndrome
46. Autoantibodies to glutamic acid decarboxylase in a patient with stiffman syndrome, epilepsy, and type I diabetes mellitus
47. Family cell lines available for research
48. Strategy for distinguishing a new DQB1 allele (DQB1*0611) from the closely related DQB1*0602 allele via sequence specific PCR or direct DNA sequencing
49. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours
50. The mitochondrial tRNALeu (URR) mutation in MELAS: Genetic, biochemical, and morphological correlations in skeletal muscle
51. Sequence and organization of the mitochondrial genome
52. Assay for islet cell antibodies: Protein A-monoclonal antibody method
53. Competitive insulin autoantibody RIA: Prospective evaluation of subjects at high risk for development of type I diabetes mellitus
54. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry
55. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
56. ICA512 autoantibody radioassay
57. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
58. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
59. Evidence that the autoantigen of restricted ICA is GAD
60. + first degree relatives of patients with type I diabetes expressing the HLA-DQB1*0602 allele
61. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes
62. Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus
63. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I
64. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM
65. HLA and insulin-dependent diabetes. A protective perspective
66. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
67. MHC-linked protection from diabetes is dissociated from clonal deletion of T cells
68. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice
69. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice
70. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity
71. The insulin gene is transcribed in the human thymus, and transcription levels correlate with allelic variation at the INS VNTR,-IDDM2 susceptibility locus for type 1 diabetes
72. Insulin expression in the thymus is modulated by INS VNTR, alleles at the IDDM2 locus